Reston Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.31M Buy
1,092
+208
+24% +$213K 0.35% 22
2026
Q1
$813K Sell
884
-14
-2% -$14.2K 0.25% 26
2025
Q4
$965K Buy
898
+204
+29% +$195K 0.3% 23
2025
Q3
$529K Sell
694
-13
-2% -$9.67K 0.17% 30
2025
Q2
$551K Buy
707
+55
+8% +$42.7K 0.19% 30
2025
Q1
$538K Buy
652
+15
+2% +$12.5K 0.22% 27
2024
Q4
$492K Buy
637
+3
+0.5% +$2.48K 0.18% 31
2024
Q3
$562K Buy
634
+1
+0.2% +$899 0.2% 29
2024
Q2
$573K Sell
633
-2
-0.3% -$1.6K 0.23% 30
2024
Q1
$494K Buy
635
+1
+0.2% +$712 0.2% 34
2023
Q4
$370K Buy
634
+21
+3% +$12.3K 0.17% 37
2023
Q3
$329K Buy
613
+9
+1% +$4.64K 0.17% 35
2023
Q2
$283K Sell
604
-13
-2% -$5.45K 0.13% 39
2023
Q1
$212K Buy
617
+13
+2% +$4.38K 0.11% 42
2022
Q4
$221K Sell
604
-82
-12% -$29.1K 0.12% 44
2022
Q3
$222K Sell
686
-219
-24% -$69.4K 0.13% 44
2022
Q2
$293K Buy
905
+10
+1% +$3K 0.16% 43
2022
Q1
$256K Buy
895
+13
+1% +$3.35K 0.13% 45
2021
Q4
$244K Buy
882
+2
+0.2% +$507 0.12% 50
2021
Q3
$203K Buy
880
+3
+0.3% +$740 0.11% 54
2021
Q2
$201K Buy
+877
New +$176K 0.1% 53

Other funds holding LLY

Reston Wealth Management's LLY Position: Q2 2026 in Review

Reston Wealth Management increased its Eli Lilly (LLY) stake by 24% in Q2 2026, buying an estimated $213K and bringing the position to 1,092 shares worth $1.31M. The position accounts for 0.35% of the portfolio, ranked #22.

Reston Wealth Management first reported a position in LLY in Q2 2021 and has held it in 21 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Reston Wealth Management held 1,092 shares of Eli Lilly worth $1.31M as of Q2 2026.
  • Reston Wealth Management bought 208 Eli Lilly shares in Q2 2026, an estimated $213K.
  • Eli Lilly made up 0.35% of Reston Wealth Management's portfolio in Q2 2026, its #22 holding.
  • Reston Wealth Management first reported a position in Eli Lilly in Q2 2021 and has held it in 21 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Reston Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.